Tetraose steroidal glycoalkaloids from potato can provide complete protection against fungi and insects

  1. Plant Breeding, Wageningen University and Research, P.O. Box 386, 6700, AJ, Wageningen, The Netherlands

Editors

  • Reviewing Editor
    Jacqueline Monaghan
    Queen's University, Kingston, Canada
  • Senior Editor
    Detlef Weigel
    Max Planck Institute for Biology Tübingen, Tübingen, Germany

Reviewer #1 (Public Review):

This manuscript conducts a classic QTL analysis to identify the molecular basis of natural variation in disease resistance. This identifies a pair of glycosyltransferases that contribute to steroidal glycoalkaloid production. Specifically altering the final hexose structure of the compound. This is somewhat similar to the work in tomatine showing that the specific hexose structure mediates the final potential bioactivity. Using the resulting transgenic complementation lines that show that the gene leads to a strong resistance phenotype to one isolate of Alternaria solani and the Colorado potato beetle. This is solid work showing the identification of a new gene and compound influencing plant biotic interactions. While the experiments are solid, the introduction, discussion and associated claims don't accurately reflect my reading of what is known and said in the current literature.

The sentence on line 53-54 is misleading. It provides only three citations on specific links between specialized metabolism and disease resistance. However, there are actually at least 40 on specific links of camalexin and indolic phytoalexins to disease resistance. Similarly there are dozens of uncited papers on benzoxazinoids, indolic glucosinolates, aliphatic glucosinolates and tomatine to both non-host and host based resistance mechanisms. This even goes as far as showing how the pathogens resist an array of these compounds. The choices in the introduction make it appear that little is known about specialized metabolism to disease resistance but I would suggest that this is not an allusion supported by the literature. I would agree that given the breadth of specialized metabolism we have a lot of knowledge about a set of them but that there are hundreds to thousands of untested compounds but to indicate that little is known is unfair to the specialized metabolism community. This is especially true as the introduction and discussion give no image of the large body of literature on specialized metabolism to insect interactions even though this is a major component of this manuscript.

I would also agree that specialized metabolism is not a conscious target of breeding programs but the work on benzoxazinoids in maize and glucosinolates in the Brassica's has shown that these compounds have been influenced by breeding programs. Similarly work on de novo domestication of multiple crops is focused on the adjustment of specialized metabolism in these crops.

I would disagree with the hint on line 49-50 and again on lines 236-239 that specialized metabolism may have less pleiotropy. This is not supported by recent work on benzoxazinoids and glucosinolates showing that they have numerous regulatory links to the plant and can be highly pleiotropic. Even the earliest avenicin work in oat showed that the deficient lines had altered root development.

My main message from the above three paragraphs is to point out that there are a number of places in the manuscript where the current state of the specialized metabolite literature is not accurately portrayed. To properly place the manuscript in the broader context, I would suggest a more even handed introduction and discussion that takes into account the current state of the specialized metabolism literature.

Is it accurate to say complete resistance to A. solani if only a single isolate of the pathogen is used? Is there evidence that I am unaware of that there are no isolates of this pathogen with saponin resistance? There are pathogens with natural tomatine resistance and this is a common feature of plant pathogens that they have genetic variation in the resistance to specialized metabolism. For example, it should be noted that Botrytis BO5.10 is a tomatine sensitive isolate and the van Kan and Hahn groups have published on isolates that are resistant to saponins. I would suggest caveating across the manuscript that this is a single isolate and that it is possible that there may be isolates with natural resistance to the steroidal glycoalkaloid?

In Figure 4b, is the infection site about 3.5 mm in size such that 3.5 mm means absolutely no infection? If not, that would mean there is some outgrowth by Alternaria and the resistance isn't complete.

Reviewer #2 (Public Review):

The study focuses on a mechanism of pest/pathogen resistance identified in Solanum commersonii, which appears to offer dominant resistance to Alternaria solani through the activity of specific glycosyltransferases which facilitate the production of tetraose glycoalkaloids in leaf tissue. The authors demonstrated that these glycoalkaloids are suppressive to the growth of multiple pathogenic ascomycetes and furthermore, that transgenic plants expressing these glycosyltransferases in susceptibleS. commersonii clones demonstrate improved resistance to a specific strain of A. solani and a genotype of Colorado Potato Beetle. The study design is straightforward, yet thorough, and does a good job demonstrating the importance of these genes in resistance. While the research findings are significant there are statements throughout the manuscript that overstate both the novelty and utility of the findings.

Title: While the protection is impressive, the title suggests that these glycoalkaloids provide protection against all fungi and insects, which is both unlikely and essentially impossible to prove. This should be changed to something more measured. This is especially true given that only a single fungus and insect were tested against transgenic plants, but would be an overstatement even with more robust evaluation.

Throughout the paper: A single isolate of A. solani and a single genotype of CPB were used in this study. While this is in line with the typical limitations of such a study, the authors need to be careful about claiming broad resistance to either of the species. Variability in fungicide tolerance and detoxification activity have been noted in both fungi and CPB, so more specific language should be used throughout (such as L213 and L221).

  1. Howard Hughes Medical Institute
  2. Wellcome Trust
  3. Max-Planck-Gesellschaft
  4. Knut and Alice Wallenberg Foundation